ASCELIA PHARMA
Ascelia Pharma is a biotechnology company. The company is focused on orphan oncology treatments.
ASCELIA PHARMA
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1999-01-01
Address:
Malmö, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.ascelia.com
Total Employee:
11+
Status:
Active
Contact:
46 735 179 118
Total Funding:
200 M SEK
Similar Organizations
Aequilibrium Pharma
Aequilibrium Pharma is a biotechnology company that develops mabs.
Alimentomica
Alimentomica is a biotechnology company that transforms scientific advancements into accessible products and ingredients.
Dermavant Sciences
Dermavant Sciences is a biotechnology company focused on dermatology.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Lyell Immunopharma
Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Employees Featured
Carl Bjartmar Chief Medical Officer @ Ascelia Pharma
Chief Medical Officer
2018-09-01
Kristian Borbos CFO @ Ascelia Pharma
CFO
2017-09-01
Magnus Corfitzen CEO @ Ascelia Pharma
CEO
2017-01-01
Stock Details
Investors List
Oresund Healthcare Management
Oresund Healthcare Management investment in Post-IPO Equity - Ascelia Pharma
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Post-IPO Equity - Ascelia Pharma
Fourth Swedish National Pension Fund
Fourth Swedish National Pension Fund investment in Post-IPO Equity - Ascelia Pharma
Healthinvest Partners
Healthinvest Partners investment in Post-IPO Equity - Ascelia Pharma
Svenska Handelsbanken
Svenska Handelsbanken investment in Post-IPO Equity - Ascelia Pharma
Official Site Inspections
http://www.ascelia.com Semrush global rank: 8.43 M Semrush visits lastest month: 534
- Host name: linux219.unoeuro.com
- IP address: 93.191.156.97
- Location: Langeskov Denmark
- Latitude: 55.3565
- Longitude: 10.5845
- Timezone: Europe/Copenhagen
- Postal: 5550
More informations about "Ascelia Pharma"
Ascelia Pharma AB - LinkedIn
Ascelia Pharma AB Pharmaceutical Manufacturing Malmö, Skane County 2,329 followers Ascelia Pharma is an oncology-dedicated orphan drug company listed on Nasdaq Stockholm under …See details»
Ascelia Pharma - Crunchbase Company Profile & Funding
Organization. Ascelia Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Ascelia Pharma is a biotechnology …See details»
Half-Year Report 2024: Orviglance Completes Clinical …
Aug 15, 2024 MALMÖ, SWEDEN / ACCESSWIRE / August 15, 2024 / Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) (ticker: ACE) today published its Half-Year Report for …See details»
Ascelia Pharma Company Profile 2024: Stock Performance
Ascelia Pharma General Information Description. Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo Sweden focused on orphan oncology It …See details»
Annual Report 2023: Solid Progress with Orviglance Phase 3 …
Apr 8, 2024 Ascelia Pharma AB Annual Financial Report ... including a significant reduction of the organization. In September, we shared our plan to complete the re-evaluation and reach …See details»
Ascelia Pharma significantly reduces organization to reach …
Aug 31, 2023 Ascelia Pharma AB , a biotech focused on improving the life of people living with rare cancer conditions, today announced a significant organizational reduction following the …See details»
Ascelia Pharma publishes annual report for 2022 - MarketScreener
Apr 13, 2023 Ascelia Pharma AB is a Sweden-based pharmaceutical company focused on the development of novel oncology therapies. The Company identifies, acquires and develops …See details»
Ascelia Pharma publishes annual report for 2022
Apr 13, 2023 Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear …See details»
Magnus Corfitzen – CEO, Ascelia Pharma, Sweden
Sep 16, 2019 Ascelia Pharma is a Swedish oncology start-up based in Malmö. CEO Magnus Corfitzen talks about the opportunities they have found in the orphan oncology drug market, …See details»
Ascelia Pharma - Products, Competitors, Financials, Employees ...
Ascelia Pharma is a biotech company focused on orphan oncology treatments within the pharmaceutical industry. Use the CB Insights Platform to explore Ascelia Pharma's full profile. …See details»
Q4 and Full Year Report 2023: Strengthened ... - MarketScreener.com
Feb 9, 2024 Ascelia Pharma AB is a Sweden-based pharmaceutical company focused on the development of novel oncology therapies. The Company identifies, acquires and develops …See details»
Orviglance® Completes Clinical Development with Successful …
Ascelia Pharma market access research and analyses with Revenue Reimbursement Solutions and Charles River Associates (2020), Triangle (2022) and Trinity (2022), incl. 75 stakeholder …See details»
Change in Number of Shares and Votes in Ascelia Pharma AB
2 days ago As of 29 November 2024, the number of shares in Ascelia Pharma AB amounts to 97,193,153 shares, of which 96,106,032 are ordinary shares with one vote each and …See details»
Ascelia Pharma significantly reduces organization to reach …
Aug 31, 2023 Ascelia Pharma AB , a biotech focused on improving the life of people living with rare cancer conditions, today announced a significant organizational reduction following the …See details»
Ascelia Pharma Successfully Meets Primary Endpoint with Strong …
May 2, 2024 Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear …See details»
Ascelia Pharma AB (ACE) Stock Price & News - Google Finance
Get the latest Ascelia Pharma AB (ACE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.See details»
Ascelia Pharma Announces Completion of Full Study Report …
Nov 6, 2024 Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear …See details»
Ascelia Pharma Finalizes Rights Issue with Runway ... - Morningstar
Sep 30, 2024 Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a …See details»
Ascelia Pharma Successfully Meets Primary Endpoint with Strong …
May 2, 2024 Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that liver imaging drug candidate, …See details»
Ascelia Pharma converts shares for delivery to incentive program ...
6 days ago Ascelia Pharma AB is a Sweden-based pharmaceutical company focused on the development of novel oncology therapies. The Company identifies, acquires and develops …See details»